Abstract
Inquisitive scientists are untiring and relentless in the hard work they perform day in and day out. In this pursuit, a researcher has to exercise their intellectual expertise in its entirety. Eventually, all credit of the invention is vested with the inventor who has the right of control over their intellectual creation. Likewise, pharmaceutical companies spend extravagantly in successfully introducing a novel drug from hundreds and thousands of lead compounds. Hence, it is a prerogative for every company to protect its innovative products from unauthorized duplication. Certainly, "patents" are the sole custodians of these products of medical intelligence - the drugs! This review focuses on the various intricacies of the drug patent system all over the world with special emphasis on India, Europe, and the United States. A note on other intellectual properties such as copyrights, trademarks, and designs is also added.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
(2009) Patent activities and issues. In: Spilker. B. Guide to Drug Development – A Comprehensive Review and Assessment. Philadelphia: Lippincott Williams & Wilkins; 2009.
(2006) Protecting the assets: patenting and intellectual property. In: Rang HP, Drug Discovery and Development – Technology in Transition. Philadelphia: Elsevier Limited
World Intellectual Property Organisation. What is Intellectual Property? [Internet]. 2014 [cited 2014 Oct 9]. Available from: http://www.wipo.int/about-ip/en/index.html#ip
Intellectual Property India. The Patents Act, 1970 [Internet]. 2013 [updated 2013 Jan 26; cited 2014 Oct 9]. Available from: http://ipindia.nic.in/ipr/patent/patent_Act_1970_28012013_book.pdf
(2006) Patent issues in drug discovery. In: Rang HP, Drug Discovery and Development – Technology in Transition. Philadelphia: Elsevier Limited
Spilker B (ed) (2009) Guide to Drug Development – A Comprehensive Review and Assessment. Lippincott Williams & Wilkins, Philadelphia, Table 109.1, Contents of a patent application; p. 1147
The United States Patent and Trademark Office. First inventor to file [Internet]. 2014 [updated 2014 Apr 2; cited 2014 Oct 9]. Available from: http://www.uspto.gov/aia_implementation/faqs_first_inventor.jsp
(2010) Patenting and commercialization of discoveries. In: Lo B. Ethical Issues in Clinical Research: A Practical Guide. Philadelphia: Lippincott Williams & Wilkins
(2009) Costs and pricing. In: Spilker. B. Guide to Drug Development – A Comprehensive Review and Assessment. Philadelphia: Lippincott Williams & Wilkins
(2009) Biotechnology. In: Spilker. B. Guide to Drug Development – A Comprehensive Review and Assessment. Philadelphia: Lippincott Williams & Wilkins
(2009) Mergers, Joint Ventures, and Alliances. In: Spilker. B. Guide to Drug Development – A Comprehensive Review and Assessment. Philadelphia: Lippincott Williams & Wilkins
Spilker. B. Guide to Drug Development – A Comprehensive Review and Assessment. Philadelphia: Lippincott Williams & Wilkins; 2009. Figure 109.2, Series of major events in the patenting of a new compound; p. 1147.
(2008) Law: Providing legal advice and protecting property. In: Freedman T. Career opportunities in Biotechnology and Drug Development. New York: Cold Spring Harbor Laboratory Press
Abbreviated New Drug Application (ANDA): Generics [Internet]. 2014 [updated 2014 Sep 18; cited 2014 Oct 9]. Available from: http://www.fda.gov/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/AbbreviatedNewDrugApplicationANDAGenerics/
European Medicines Agency: Data exclusivity, market protection and paediatric rewards [Internet]. 2013 [updated 2013 Apr 26; cited 2015 Jan 12]. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Presentation/2013/05/WC500143122.pdf
U.S. Food and Drug Administration: Frequently Asked Questions on Patents and Exclusivity [Internet]. 2014 [updated 2014 July 18; cited 2015 Jan 12]. Available from: http://www.fda.gov/Drugs/DevelopmentApprovalProcess/ucm079031.htm#
(2008) Intellectual property: types, rights and caveats. In: Malhotra S, Shafiq N, Pandhi P. A Comprehensive Clinical Research Manual. New Delhi: Jaypee Brothers Medical Publishers (P) Ltd.
(2007) Human genomic variation. In: Campbell MA, Heyer LJ. Discovering Genomics, Proteomics, & Bioinformatics. 2nd ed. India: Dorling Kindersley Pvt. Ltd.
Novartis loses Glivec patent battle in India [Internet]. 2013 [updated 2013 Apr 1; cited 2014 Dec 20]. Available from: http://www.wsj.com/articles/SB1000142412788732329650457839567258
European patent office – Glossary [Internet]. 2012 [updated 2012 Dec 20; cited 2014 Dec 20]. Available from: http://www.epo.org/service-support/glossary.html
About IP5 co-operation - Five IP Offices [Internet]. 2014 [updated 2014 Dec 3; cited 2014 Dec 20]. Available from: http://www.fiveipoffices.org/about.html
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Raj, G.M., Priyadarshini, R. & Mathaiyan, J. Drug patents and intellectual property rights. Eur J Clin Pharmacol 71, 403–409 (2015). https://doi.org/10.1007/s00228-015-1811-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-015-1811-5